Novo Nordisk reportedly faces US congressional review for halting sales of long-acting insulin Levemir in the US
soul1987
发表于 2024-7-16 17:07:13
3123
0
0
Novo Nordisk is reportedly facing scrutiny from the US Congress for discontinuing the sale of long-acting insulin Levemir in the US.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- The US Congress is targeting inheritance preferences in the process of college enrollment and admission
- Two parties in the US Congress reach a $1.66 trillion spending agreement
- Lilly Ultra Long acting Insulin Phase III Clinical Success
- Ministry of Foreign Affairs: Countermeasures against US Congressman McGovern
- Novo Nordisk to invest 864 million Brazilian reals to renovate insulin factory in Brazil
- Novo Nordisk to invest 864 million Brazilian reals to renovate insulin factory in Brazil
- Tesla's market value evaporated by over 520 billion yuan overnight! The panic index surged by 23% at one point! Yellen warns US Congress
